Table 1 Acute effects outcomes grouped by domain, presented as mean ± standard deviation, together with statistical significance and effect size (*p < 0.05, **p < 0.01, ***p < 0.001).

From: Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception

Outcome

Mean ± SD

Psilocybin

Mean ± SD

Control

p-value

RBC’s r

Eye-tracking metrics

    

N

77.00 ± 17.19

70.80 ± 10.32

0.454

0.23

ds

146.43 ± 27.42

170.19 ± 23.89

0.007**

−0.76

dt

0.39 ± 0.08

0.41 ± 0.05

0.454

−0.23

ds2

354.78 ± 41.93

381.87 ± 36.33

0.035*

−0.62

σ(ds)

129.93 ± 17.68

143.22 ± 19.32

0.018*

−0.68

σ(ds2)

210.56 ± 17.36

220.96 ± 15.35

0.035*

−0.62

σ(dt)

0.20 ± 0.03

0.20 ± 0.05

0.978

0.02

Shannon entropy (bw = 40)

5.83 ± 0.14

5.90 ± 0.13

0.035*

−0.62

Shannon entropy (bw = 60)

5.12 ± 0.15

5.19 ± 0.13

0.041*

−0.6

Shannon entropy (bw = 80)

4.59 ± 0.15

4.67 ± 0.12

0.022*

−0.67

Shannon entropy (bw = 100)

4.18 ± 0.15

4.25 ± 0.12

0.022*

−0.67

Intensity effects ratings

    

VAS 1 total

17.56 ± 8.47

9.91 ± 3.80

0.002 **

0.8

VAS 2 total

21.83 ± 7.79

11.87 ± 5.19

0.0001***

0.84

VAS 3 total

20.00 ± 7.56

9.35 ± 2.76

8e-5 ***

0.96

VAS 4 total

14.95 ± 8.00

7.91 ± 1.35

0.001 **

0.87

Trial-wise ratings

    

Emotional valence

0.52 ± 0.35

0.41 ± 0.35

0.232

0.3

Beauty rating

1.15 ± 0.6

1.13 ± 0.51

0.708

0.1

AEQ factors ratings

   

Cohen’ s d

Emotional

18.38 ± 5.55

15.26 ± 5.79

0.004 (**)

0.55

Cultural

19.48 ± 6.12

20.74 ± 6.35

0.341

0.2

Perceptual

16.14 ± 3.53

16.78 ± 4.08

0.494

0.17

Understanding

17.38 ± 5.36

18.04 ± 4.81

0.658

0.13

Flow conditions

11.19 ± 4.38

10.22 ± 2.80

0.287

0.27

Flow experience

19.81 ± 4.37

16.78 ± 4.65

0.015 (*)

0.67